Cargando…

GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?

[Figure: see text]

Detalles Bibliográficos
Autores principales: Stoll, Lisa, Lo, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504427/
https://www.ncbi.nlm.nih.gov/pubmed/37719426
http://dx.doi.org/10.1016/j.jacbts.2023.03.022
_version_ 1785106719844597760
author Stoll, Lisa
Lo, James C.
author_facet Stoll, Lisa
Lo, James C.
author_sort Stoll, Lisa
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-10504427
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105044272023-09-17 GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? Stoll, Lisa Lo, James C. JACC Basic Transl Sci Original Research - Preclinical [Figure: see text] Elsevier 2023-08-28 /pmc/articles/PMC10504427/ /pubmed/37719426 http://dx.doi.org/10.1016/j.jacbts.2023.03.022 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research - Preclinical
Stoll, Lisa
Lo, James C.
GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?
title GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?
title_full GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?
title_fullStr GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?
title_full_unstemmed GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?
title_short GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?
title_sort glp-1 receptor agonists, the holy grail preventing atrial fibrillation in patients with t2d?
topic Original Research - Preclinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504427/
https://www.ncbi.nlm.nih.gov/pubmed/37719426
http://dx.doi.org/10.1016/j.jacbts.2023.03.022
work_keys_str_mv AT stolllisa glp1receptoragoniststheholygrailpreventingatrialfibrillationinpatientswitht2d
AT lojamesc glp1receptoragoniststheholygrailpreventingatrialfibrillationinpatientswitht2d